Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.71686686 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.71686686 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.42747819 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.42747819 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 7.01766823 |
6 | epoxygenase P450 pathway (GO:0019373) | 6.68892486 |
7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.52024090 |
8 | indole-containing compound catabolic process (GO:0042436) | 6.40026212 |
9 | indolalkylamine catabolic process (GO:0046218) | 6.40026212 |
10 | tryptophan catabolic process (GO:0006569) | 6.40026212 |
11 | glyoxylate metabolic process (GO:0046487) | 6.28396907 |
12 | kynurenine metabolic process (GO:0070189) | 6.13359877 |
13 | blood coagulation, intrinsic pathway (GO:0007597) | 6.07239745 |
14 | tryptophan metabolic process (GO:0006568) | 6.02846172 |
15 | cysteine metabolic process (GO:0006534) | 5.90831531 |
16 | bile acid biosynthetic process (GO:0006699) | 5.89205931 |
17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.84949317 |
18 | serine family amino acid catabolic process (GO:0009071) | 5.51512712 |
19 | urea cycle (GO:0000050) | 5.49203750 |
20 | urea metabolic process (GO:0019627) | 5.49203750 |
21 | sulfur amino acid catabolic process (GO:0000098) | 5.45325446 |
22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.39043259 |
23 | homocysteine metabolic process (GO:0050667) | 5.23157216 |
24 | negative regulation of fibrinolysis (GO:0051918) | 5.19743578 |
25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.14519255 |
26 | aromatic amino acid family metabolic process (GO:0009072) | 5.11911609 |
27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.11201145 |
28 | oxidative demethylation (GO:0070989) | 5.07484137 |
29 | nitrogen cycle metabolic process (GO:0071941) | 5.06966039 |
30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.99412804 |
31 | protein carboxylation (GO:0018214) | 4.99412804 |
32 | bile acid metabolic process (GO:0008206) | 4.98695660 |
33 | regulation of fibrinolysis (GO:0051917) | 4.98419445 |
34 | complement activation, alternative pathway (GO:0006957) | 4.97973232 |
35 | regulation of plasminogen activation (GO:0010755) | 4.95454679 |
36 | regulation of protein activation cascade (GO:2000257) | 4.94616514 |
37 | amino-acid betaine metabolic process (GO:0006577) | 4.87550719 |
38 | * lysine metabolic process (GO:0006553) | 4.87463652 |
39 | * lysine catabolic process (GO:0006554) | 4.87463652 |
40 | * alpha-amino acid catabolic process (GO:1901606) | 4.81419905 |
41 | phenylpropanoid metabolic process (GO:0009698) | 4.78348066 |
42 | tyrosine metabolic process (GO:0006570) | 4.76098404 |
43 | serine family amino acid metabolic process (GO:0009069) | 4.66804376 |
44 | intestinal cholesterol absorption (GO:0030299) | 4.65837168 |
45 | glycine metabolic process (GO:0006544) | 4.64873356 |
46 | regulation of complement activation (GO:0030449) | 4.62184549 |
47 | cellular ketone body metabolic process (GO:0046950) | 4.58709551 |
48 | drug catabolic process (GO:0042737) | 4.56249325 |
49 | regulation of cholesterol esterification (GO:0010872) | 4.53439232 |
50 | indolalkylamine metabolic process (GO:0006586) | 4.52646062 |
51 | urate metabolic process (GO:0046415) | 4.52058282 |
52 | * cellular amino acid catabolic process (GO:0009063) | 4.48433936 |
53 | regulation of triglyceride catabolic process (GO:0010896) | 4.48076356 |
54 | glutamate metabolic process (GO:0006536) | 4.46864832 |
55 | negative regulation of cholesterol transport (GO:0032375) | 4.46586276 |
56 | negative regulation of sterol transport (GO:0032372) | 4.46586276 |
57 | serine family amino acid biosynthetic process (GO:0009070) | 4.46085998 |
58 | reverse cholesterol transport (GO:0043691) | 4.44625625 |
59 | cellular modified amino acid catabolic process (GO:0042219) | 4.42010811 |
60 | amine catabolic process (GO:0009310) | 4.40885878 |
61 | cellular biogenic amine catabolic process (GO:0042402) | 4.40885878 |
62 | ethanol metabolic process (GO:0006067) | 4.39875127 |
63 | protein-lipid complex remodeling (GO:0034368) | 4.39082411 |
64 | macromolecular complex remodeling (GO:0034367) | 4.39082411 |
65 | plasma lipoprotein particle remodeling (GO:0034369) | 4.39082411 |
66 | drug transmembrane transport (GO:0006855) | 4.38716500 |
67 | negative regulation of hemostasis (GO:1900047) | 4.38053939 |
68 | negative regulation of blood coagulation (GO:0030195) | 4.38053939 |
69 | triglyceride homeostasis (GO:0070328) | 4.36439539 |
70 | acylglycerol homeostasis (GO:0055090) | 4.36439539 |
71 | protein activation cascade (GO:0072376) | 4.35275237 |
72 | coenzyme catabolic process (GO:0009109) | 4.33893489 |
73 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.32317963 |
74 | cellular glucuronidation (GO:0052695) | 4.25984698 |
75 | benzene-containing compound metabolic process (GO:0042537) | 4.25401871 |
76 | S-adenosylmethionine metabolic process (GO:0046500) | 4.24123432 |
77 | negative regulation of protein activation cascade (GO:2000258) | 4.23296649 |
78 | imidazole-containing compound metabolic process (GO:0052803) | 4.22610825 |
79 | bile acid and bile salt transport (GO:0015721) | 4.20011795 |
80 | ethanol oxidation (GO:0006069) | 4.17883854 |
81 | aldehyde catabolic process (GO:0046185) | 4.15414953 |
82 | phospholipid efflux (GO:0033700) | 4.15182360 |
83 | short-chain fatty acid metabolic process (GO:0046459) | 4.13911726 |
84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.11998361 |
85 | exogenous drug catabolic process (GO:0042738) | 4.07464942 |
86 | plasma lipoprotein particle clearance (GO:0034381) | 4.02784741 |
87 | negative regulation of coagulation (GO:0050819) | 3.99227577 |
88 | arginine metabolic process (GO:0006525) | 3.99216175 |
89 | ketone body metabolic process (GO:1902224) | 3.96497739 |
90 | negative regulation of wound healing (GO:0061045) | 3.94723144 |
91 | acute-phase response (GO:0006953) | 3.94096829 |
92 | alkaloid metabolic process (GO:0009820) | 3.93169636 |
93 | negative regulation of lipase activity (GO:0060192) | 3.92191142 |
94 | * carboxylic acid catabolic process (GO:0046395) | 3.92084479 |
95 | * organic acid catabolic process (GO:0016054) | 3.92084479 |
96 | heme transport (GO:0015886) | 3.90767844 |
97 | positive regulation of blood coagulation (GO:0030194) | 3.90056349 |
98 | positive regulation of hemostasis (GO:1900048) | 3.90056349 |
99 | uronic acid metabolic process (GO:0006063) | 3.84807062 |
100 | glucuronate metabolic process (GO:0019585) | 3.84807062 |
101 | regulation of humoral immune response (GO:0002920) | 3.83532988 |
102 | cholesterol efflux (GO:0033344) | 3.81401106 |
103 | complement activation, classical pathway (GO:0006958) | 3.80981531 |
104 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80684734 |
105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.77152610 |
106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.77152610 |
107 | 2-oxoglutarate metabolic process (GO:0006103) | 3.74467998 |
108 | complement activation (GO:0006956) | 3.73375393 |
109 | low-density lipoprotein particle remodeling (GO:0034374) | 3.73125092 |
110 | regulation of cholesterol homeostasis (GO:2000188) | 3.72921796 |
111 | fibrinolysis (GO:0042730) | 3.71215663 |
112 | plasma lipoprotein particle assembly (GO:0034377) | 3.67897450 |
113 | plasma lipoprotein particle organization (GO:0071827) | 3.66594852 |
114 | drug transport (GO:0015893) | 3.65731428 |
115 | * acetyl-CoA metabolic process (GO:0006084) | 3.64226029 |
116 | cofactor catabolic process (GO:0051187) | 3.62737667 |
117 | drug metabolic process (GO:0017144) | 3.61947167 |
118 | fatty acid beta-oxidation (GO:0006635) | 3.61682213 |
119 | cholesterol homeostasis (GO:0042632) | 3.61187696 |
120 | carnitine metabolic process (GO:0009437) | 3.61112359 |
121 | fatty acid oxidation (GO:0019395) | 3.60742788 |
122 | monocarboxylic acid catabolic process (GO:0072329) | 3.60045483 |
123 | positive regulation of coagulation (GO:0050820) | 3.59207516 |
124 | * aspartate family amino acid catabolic process (GO:0009068) | 3.58623010 |
125 | sterol homeostasis (GO:0055092) | 3.57550063 |
126 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.57159520 |
127 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.57159520 |
128 | phospholipid homeostasis (GO:0055091) | 3.56516931 |
129 | NAD biosynthetic process (GO:0009435) | 3.56284678 |
130 | negative regulation of complement activation (GO:0045916) | 3.54785164 |
131 | flavonoid metabolic process (GO:0009812) | 3.53794741 |
132 | sodium-independent organic anion transport (GO:0043252) | 3.45841182 |
133 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.40744494 |
134 | regulation of apoptotic cell clearance (GO:2000425) | 3.40695052 |
135 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.40638835 |
136 | cytolysis (GO:0019835) | 3.39666264 |
137 | L-serine metabolic process (GO:0006563) | 3.37688027 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.46237496 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.28178920 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92013666 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48430928 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.16436969 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.04787280 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89326640 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.10768809 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97362726 |
10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.77550501 |
11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.24410091 |
12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.16142498 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13811142 |
14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.12554382 |
15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0173893 |
16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.91177553 |
17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.77949514 |
18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.70348951 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65254155 |
20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64573520 |
21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59487671 |
22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54383346 |
23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53464691 |
24 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.49542317 |
25 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.42159096 |
26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.37034784 |
27 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.35985495 |
28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34690950 |
29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33444030 |
30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.32714106 |
31 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32204342 |
32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32049557 |
33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27552652 |
34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25680689 |
35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24326377 |
36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24103006 |
37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22693249 |
38 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21056685 |
39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20688718 |
40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18377890 |
41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.16810559 |
42 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16568376 |
43 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14392466 |
44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14090517 |
45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13762177 |
46 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13598757 |
47 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12624276 |
48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12365911 |
49 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12039777 |
50 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12039777 |
51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11079938 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07650777 |
53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04651952 |
54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03562736 |
55 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03097436 |
56 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02672151 |
57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02453509 |
58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02314150 |
59 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02069835 |
60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00909136 |
61 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00655213 |
62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98676453 |
63 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98676453 |
64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98452260 |
65 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96675607 |
66 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95645418 |
67 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93305299 |
68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92598574 |
69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91173334 |
70 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90839475 |
71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90053579 |
72 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89800676 |
73 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89577133 |
74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89577133 |
75 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.89144451 |
76 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.87594431 |
77 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.87430974 |
78 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87420287 |
79 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86694229 |
80 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86192013 |
81 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.85285667 |
82 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.85169444 |
83 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84944117 |
84 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.84030028 |
85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83249408 |
86 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.83243340 |
87 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83125929 |
88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83002739 |
89 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82938258 |
90 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.82913589 |
91 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.82547272 |
92 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.82455760 |
93 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82248711 |
94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82227559 |
95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81696274 |
96 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81275989 |
97 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81134541 |
98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81078260 |
99 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81069586 |
100 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.77527524 |
101 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.77367240 |
102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77310036 |
103 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.77308540 |
104 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.77191706 |
105 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77077229 |
106 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.77063476 |
107 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76706338 |
108 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76415983 |
109 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76026849 |
110 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.75903916 |
111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74160718 |
112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.73550114 |
113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73441481 |
114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72349596 |
115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68147315 |
116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67137226 |
117 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65148295 |
118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63576819 |
119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63318079 |
120 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63018479 |
121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63016886 |
122 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61708404 |
123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59957696 |
124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59453915 |
125 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.59201015 |
126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58568898 |
127 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.55741683 |
128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.55060844 |
129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54473981 |
130 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54068738 |
131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53600397 |
132 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.52673914 |
133 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52582696 |
134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51699468 |
135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.51239669 |
136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.51239669 |
137 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50252729 |
138 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.48727530 |
139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48268697 |
140 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47746309 |
141 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46865566 |
142 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.45301000 |
143 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44072460 |
144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44050395 |
145 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.44001688 |
146 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43690866 |
147 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42970222 |
148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42618260 |
149 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42186460 |
150 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.42069445 |
151 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.41789186 |
152 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.40966938 |
153 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.39782558 |
154 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.39346799 |
155 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39133175 |
156 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.39043857 |
157 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.38451510 |
158 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38274302 |
159 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.38249953 |
160 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37496230 |
161 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.37253206 |
162 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37085218 |
163 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.36009025 |
164 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.36000799 |
165 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.35556738 |
166 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.35206907 |
167 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35046013 |
168 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.34488079 |
169 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.34349618 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.23773502 |
2 | MP0005360_urolithiasis | 8.02684131 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.25255085 |
4 | MP0005365_abnormal_bile_salt | 5.96840564 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.10155254 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.36080883 |
7 | MP0003252_abnormal_bile_duct | 3.91502899 |
8 | MP0010329_abnormal_lipoprotein_level | 3.34723413 |
9 | MP0005332_abnormal_amino_acid | 3.24174056 |
10 | MP0003195_calcinosis | 3.09984190 |
11 | MP0009840_abnormal_foam_cell | 2.93657835 |
12 | MP0005083_abnormal_biliary_tract | 2.79774728 |
13 | MP0004019_abnormal_vitamin_homeostasis | 2.66579275 |
14 | MP0001666_abnormal_nutrient_absorption | 2.51380716 |
15 | MP0002138_abnormal_hepatobiliary_system | 2.29501450 |
16 | MP0003122_maternal_imprinting | 2.24134345 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.12492851 |
18 | MP0000609_abnormal_liver_physiology | 2.05394968 |
19 | MP0002118_abnormal_lipid_homeostasis | 2.01287820 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.86554814 |
21 | MP0001764_abnormal_homeostasis | 1.72071103 |
22 | MP0003868_abnormal_feces_composition | 1.71578636 |
23 | MP0009643_abnormal_urine_homeostasis | 1.65116658 |
24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61718152 |
25 | MP0003186_abnormal_redox_activity | 1.48142839 |
26 | MP0005451_abnormal_body_composition | 1.40438093 |
27 | MP0009697_abnormal_copulation | 1.34569677 |
28 | MP0005636_abnormal_mineral_homeostasis | 1.23117208 |
29 | MP0003011_delayed_dark_adaptation | 1.20134584 |
30 | MP0000598_abnormal_liver_morphology | 1.15850427 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.13031379 |
32 | MP0005647_abnormal_sex_gland | 1.05485447 |
33 | MP0005551_abnormal_eye_electrophysiolog | 1.05203515 |
34 | MP0003656_abnormal_erythrocyte_physiolo | 1.03628777 |
35 | MP0001984_abnormal_olfaction | 1.00145455 |
36 | MP0009764_decreased_sensitivity_to | 0.98852358 |
37 | MP0006292_abnormal_olfactory_placode | 0.97746351 |
38 | MP0004043_abnormal_pH_regulation | 0.96471338 |
39 | MP0001756_abnormal_urination | 0.94397902 |
40 | MP0006036_abnormal_mitochondrial_physio | 0.94345541 |
41 | MP0002909_abnormal_adrenal_gland | 0.92701496 |
42 | MP0009763_increased_sensitivity_to | 0.92239136 |
43 | MP0000604_amyloidosis | 0.91983114 |
44 | MP0002254_reproductive_system_inflammat | 0.90506516 |
45 | MP0003121_genomic_imprinting | 0.88999463 |
46 | MP0005670_abnormal_white_adipose | 0.88732188 |
47 | MP0005084_abnormal_gallbladder_morpholo | 0.88217816 |
48 | MP0009642_abnormal_blood_homeostasis | 0.87496593 |
49 | MP0002132_abnormal_respiratory_system | 0.83709551 |
50 | MP0001915_intracranial_hemorrhage | 0.83371675 |
51 | MP0008469_abnormal_protein_level | 0.83356401 |
52 | MP0000566_synostosis | 0.83066783 |
53 | MP0005408_hypopigmentation | 0.82521533 |
54 | MP0005377_hearing/vestibular/ear_phenot | 0.82220198 |
55 | MP0003878_abnormal_ear_physiology | 0.82220198 |
56 | MP0002876_abnormal_thyroid_physiology | 0.81328818 |
57 | MP0003123_paternal_imprinting | 0.80902143 |
58 | MP0002136_abnormal_kidney_physiology | 0.80275590 |
59 | MP0005376_homeostasis/metabolism_phenot | 0.79383765 |
60 | MP0003136_yellow_coat_color | 0.77741137 |
61 | MP0005220_abnormal_exocrine_pancreas | 0.76863606 |
62 | MP0003890_abnormal_embryonic-extraembry | 0.75277093 |
63 | MP0009765_abnormal_xenobiotic_induced | 0.74736388 |
64 | MP0002078_abnormal_glucose_homeostasis | 0.74595545 |
65 | MP0001661_extended_life_span | 0.71866391 |
66 | MP0003879_abnormal_hair_cell | 0.71806366 |
67 | MP0010368_abnormal_lymphatic_system | 0.70259425 |
68 | MP0005646_abnormal_pituitary_gland | 0.70083591 |
69 | MP0005266_abnormal_metabolism | 0.69451754 |
70 | MP0005535_abnormal_body_temperature | 0.69246453 |
71 | MP0002938_white_spotting | 0.69242268 |
72 | MP0005187_abnormal_penis_morphology | 0.69170041 |
73 | MP0002971_abnormal_brown_adipose | 0.64952753 |
74 | MP0002090_abnormal_vision | 0.63300082 |
75 | MP0009053_abnormal_anal_canal | 0.63280146 |
76 | MP0003283_abnormal_digestive_organ | 0.62208756 |
77 | MP0006035_abnormal_mitochondrial_morpho | 0.62179955 |
78 | MP0002282_abnormal_trachea_morphology | 0.61718584 |
79 | MP0003567_abnormal_fetal_cardiomyocyte | 0.61527835 |
80 | MP0005334_abnormal_fat_pad | 0.60307326 |
81 | MP0004133_heterotaxia | 0.59227717 |
82 | MP0001324_abnormal_eye_pigmentation | 0.58687515 |
83 | MP0004142_abnormal_muscle_tone | 0.58648136 |
84 | MP0001765_abnormal_ion_homeostasis | 0.58471917 |
85 | MP0002928_abnormal_bile_duct | 0.56882124 |
86 | MP0003329_amyloid_beta_deposits | 0.56332541 |
87 | MP0003690_abnormal_glial_cell | 0.56253359 |
88 | MP0002089_abnormal_postnatal_growth/wei | 0.55936535 |
89 | MP0005395_other_phenotype | 0.55656591 |
90 | MP0001986_abnormal_taste_sensitivity | 0.55242993 |
91 | MP0004130_abnormal_muscle_cell | 0.54999109 |
92 | MP0003638_abnormal_response/metabolism_ | 0.53949459 |
93 | MP0008877_abnormal_DNA_methylation | 0.50440776 |
94 | MP0003718_maternal_effect | 0.50258157 |
95 | MP0002638_abnormal_pupillary_reflex | 0.47265953 |
96 | MP0003787_abnormal_imprinting | 0.46825955 |
97 | MP0001944_abnormal_pancreas_morphology | 0.46675007 |
98 | MP0003632_abnormal_nervous_system | 0.46467733 |
99 | MP0003633_abnormal_nervous_system | 0.46331989 |
100 | MP0000639_abnormal_adrenal_gland | 0.46224146 |
101 | MP0005666_abnormal_adipose_tissue | 0.45919052 |
102 | MP0005410_abnormal_fertilization | 0.45913099 |
103 | MP0001529_abnormal_vocalization | 0.45264842 |
104 | MP0005448_abnormal_energy_balance | 0.44438237 |
105 | MP0005379_endocrine/exocrine_gland_phen | 0.43955670 |
106 | MP0002168_other_aberrant_phenotype | 0.42388598 |
107 | MP0009672_abnormal_birth_weight | 0.42102035 |
108 | MP0003953_abnormal_hormone_level | 0.41910455 |
109 | MP0002557_abnormal_social/conspecific_i | 0.41008496 |
110 | MP0002796_impaired_skin_barrier | 0.41002879 |
111 | MP0008873_increased_physiological_sensi | 0.40627544 |
112 | MP0009046_muscle_twitch | 0.40214955 |
113 | MP0009745_abnormal_behavioral_response | 0.40015588 |
114 | MP0008872_abnormal_physiological_respon | 0.39894181 |
115 | MP0005058_abnormal_lysosome_morphology | 0.39776926 |
116 | MP0006072_abnormal_retinal_apoptosis | 0.39290410 |
117 | MP0000230_abnormal_systemic_arterial | 0.38333566 |
118 | MP0008874_decreased_physiological_sensi | 0.38076437 |
119 | MP0004782_abnormal_surfactant_physiolog | 0.34687861 |
120 | MP0004264_abnormal_extraembryonic_tissu | 0.34169059 |
121 | MP0002135_abnormal_kidney_morphology | 0.34051275 |
122 | MP0005166_decreased_susceptibility_to | 0.33451904 |
123 | MP0003075_altered_response_to | 0.33231391 |
124 | MP0002822_catalepsy | 0.32630795 |
125 | MP0005464_abnormal_platelet_physiology | 0.31447300 |
126 | MP0000538_abnormal_urinary_bladder | 0.30884499 |
127 | MP0009115_abnormal_fat_cell | 0.29996378 |
128 | MP0005248_abnormal_Harderian_gland | 0.29994491 |
129 | MP0003724_increased_susceptibility_to | 0.28801288 |
130 | MP0002970_abnormal_white_adipose | 0.27558045 |
131 | MP0009384_cardiac_valve_regurgitation | 0.26826489 |
132 | MP0002837_dystrophic_cardiac_calcinosis | 0.25795936 |
133 | MP0000579_abnormal_nail_morphology | 0.25000506 |
134 | MP0003436_decreased_susceptibility_to | 0.23781854 |
135 | MP0010234_abnormal_vibrissa_follicle | 0.23029983 |
136 | MP0001845_abnormal_inflammatory_respons | 0.22703245 |
137 | MP0005167_abnormal_blood-brain_barrier | 0.22701055 |
138 | MP0000249_abnormal_blood_vessel | 0.22031895 |
139 | MP0001853_heart_inflammation | 0.21638420 |
140 | MP0003959_abnormal_lean_body | 0.20912266 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.21473522 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.99171780 |
3 | Deep venous thrombosis (HP:0002625) | 6.68831529 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.44288553 |
5 | Xanthomatosis (HP:0000991) | 5.97130009 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.88535314 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.83345946 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.00288653 |
9 | Complement deficiency (HP:0004431) | 4.80822575 |
10 | Hyperglycinemia (HP:0002154) | 4.79685595 |
11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.78018230 |
12 | Hyperammonemia (HP:0001987) | 4.76643702 |
13 | Hyperglycinuria (HP:0003108) | 4.70663798 |
14 | Ketosis (HP:0001946) | 4.53853912 |
15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.51471885 |
16 | Abnormality of glycine metabolism (HP:0010895) | 4.51471885 |
17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.44293393 |
18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.44098075 |
19 | Joint hemorrhage (HP:0005261) | 4.35196327 |
20 | Hypolipoproteinemia (HP:0010981) | 4.35105224 |
21 | Epidermoid cyst (HP:0200040) | 4.17882513 |
22 | Abnormality of methionine metabolism (HP:0010901) | 4.12727427 |
23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.96424069 |
24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.94849156 |
25 | Fat malabsorption (HP:0002630) | 3.94562173 |
26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.93124041 |
27 | Hypoglycemic coma (HP:0001325) | 3.77119210 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 3.74931855 |
29 | Gout (HP:0001997) | 3.61944141 |
30 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.58292649 |
31 | Abnormality of nucleobase metabolism (HP:0010932) | 3.52241423 |
32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.49813825 |
33 | Ketoacidosis (HP:0001993) | 3.48778073 |
34 | Abnormality of complement system (HP:0005339) | 3.46412545 |
35 | Delayed CNS myelination (HP:0002188) | 3.46318997 |
36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.32313496 |
37 | Abnormality of purine metabolism (HP:0004352) | 3.31800114 |
38 | Abnormality of serum amino acid levels (HP:0003112) | 3.28299010 |
39 | Hypercholesterolemia (HP:0003124) | 3.27167005 |
40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23351926 |
41 | Hyperbilirubinemia (HP:0002904) | 3.20424543 |
42 | Metabolic acidosis (HP:0001942) | 2.98474301 |
43 | Hepatocellular carcinoma (HP:0001402) | 2.97009421 |
44 | Steatorrhea (HP:0002570) | 2.96840241 |
45 | Nephritis (HP:0000123) | 2.94835897 |
46 | Vascular calcification (HP:0004934) | 2.89883581 |
47 | Lethargy (HP:0001254) | 2.84642738 |
48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.83411600 |
49 | Dicarboxylic aciduria (HP:0003215) | 2.83411600 |
50 | Arthropathy (HP:0003040) | 2.75420148 |
51 | Spastic diplegia (HP:0001264) | 2.71015123 |
52 | Myocardial infarction (HP:0001658) | 2.63051383 |
53 | Hypochromic microcytic anemia (HP:0004840) | 2.62492372 |
54 | Alkalosis (HP:0001948) | 2.62340287 |
55 | Spontaneous abortion (HP:0005268) | 2.61798385 |
56 | Generalized aminoaciduria (HP:0002909) | 2.61727796 |
57 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.61370963 |
58 | Proximal tubulopathy (HP:0000114) | 2.58233859 |
59 | Cardiovascular calcification (HP:0011915) | 2.55734561 |
60 | Osteomalacia (HP:0002749) | 2.54315521 |
61 | Malnutrition (HP:0004395) | 2.53861108 |
62 | Hyperuricemia (HP:0002149) | 2.52876462 |
63 | Increased purine levels (HP:0004368) | 2.52876462 |
64 | Irritability (HP:0000737) | 2.52626943 |
65 | Skin nodule (HP:0200036) | 2.51264299 |
66 | Cerebral edema (HP:0002181) | 2.51013457 |
67 | Systemic lupus erythematosus (HP:0002725) | 2.47087641 |
68 | Neonatal onset (HP:0003623) | 2.46158095 |
69 | Fair hair (HP:0002286) | 2.42239239 |
70 | Enlarged kidneys (HP:0000105) | 2.36542560 |
71 | Hypoglycemic seizures (HP:0002173) | 2.34818133 |
72 | Vomiting (HP:0002013) | 2.33204967 |
73 | Rickets (HP:0002748) | 2.31894476 |
74 | Gingival bleeding (HP:0000225) | 2.29751598 |
75 | Abnormality of proline metabolism (HP:0010907) | 2.27247495 |
76 | Hydroxyprolinuria (HP:0003080) | 2.27247495 |
77 | Reduced antithrombin III activity (HP:0001976) | 2.25854423 |
78 | Late onset (HP:0003584) | 2.25666547 |
79 | Sensorimotor neuropathy (HP:0007141) | 2.23851074 |
80 | Mitral stenosis (HP:0001718) | 2.22405861 |
81 | Acanthocytosis (HP:0001927) | 2.19328960 |
82 | Abnormal gallbladder morphology (HP:0012437) | 2.18829648 |
83 | Abnormal biliary tract physiology (HP:0012439) | 2.18741019 |
84 | Bile duct proliferation (HP:0001408) | 2.18741019 |
85 | Hyperphosphaturia (HP:0003109) | 2.18156793 |
86 | Glycosuria (HP:0003076) | 2.17044806 |
87 | Abnormality of urine glucose concentration (HP:0011016) | 2.17044806 |
88 | Pancreatitis (HP:0001733) | 2.16721551 |
89 | Glomerulonephritis (HP:0000099) | 2.14913953 |
90 | Cholelithiasis (HP:0001081) | 2.13461714 |
91 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.11133840 |
92 | Purpura (HP:0000979) | 2.10924355 |
93 | Esophageal varix (HP:0002040) | 2.10502950 |
94 | Abnormal gallbladder physiology (HP:0012438) | 2.06364996 |
95 | Cholecystitis (HP:0001082) | 2.06364996 |
96 | Hypothermia (HP:0002045) | 2.05386911 |
97 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.04363607 |
98 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.04363607 |
99 | Opisthotonus (HP:0002179) | 2.01774309 |
100 | Brushfield spots (HP:0001088) | 1.99800589 |
101 | Hypophosphatemic rickets (HP:0004912) | 1.98925761 |
102 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93699282 |
103 | Abnormal cartilage morphology (HP:0002763) | 1.93188371 |
104 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92871299 |
105 | Thrombophlebitis (HP:0004418) | 1.92677995 |
106 | Hepatoblastoma (HP:0002884) | 1.89355583 |
107 | Amyloidosis (HP:0011034) | 1.88484672 |
108 | Pulmonary embolism (HP:0002204) | 1.88234039 |
109 | Poikilocytosis (HP:0004447) | 1.87807334 |
110 | Confusion (HP:0001289) | 1.87752935 |
111 | Bifid scrotum (HP:0000048) | 1.87602666 |
112 | Menorrhagia (HP:0000132) | 1.87101993 |
113 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86956347 |
114 | Nephrolithiasis (HP:0000787) | 1.86245542 |
115 | Abnormality of vitamin metabolism (HP:0100508) | 1.85188512 |
116 | Abnormality of the gallbladder (HP:0005264) | 1.83801106 |
117 | Elevated alkaline phosphatase (HP:0003155) | 1.80474562 |
118 | Hemorrhage of the eye (HP:0011885) | 1.79237174 |
119 | Retinal atrophy (HP:0001105) | 1.77812135 |
120 | Facial shape deformation (HP:0011334) | 1.70643760 |
121 | Potter facies (HP:0002009) | 1.70643760 |
122 | Vaginal fistula (HP:0004320) | 1.69617252 |
123 | Abnormal urine phosphate concentration (HP:0012599) | 1.68756445 |
124 | Increased serum pyruvate (HP:0003542) | 1.64334098 |
125 | Hyperglycemia (HP:0003074) | 1.57624362 |
126 | Symptomatic seizures (HP:0011145) | 1.57343451 |
127 | Neoplasm of the liver (HP:0002896) | 1.54776494 |
128 | Status epilepticus (HP:0002133) | 1.54471586 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.71142311 |
2 | FGFR4 | 4.43822090 |
3 | SIK1 | 4.19224273 |
4 | ERN1 | 3.82242343 |
5 | ERBB4 | 2.94426683 |
6 | INSRR | 2.71153782 |
7 | BMPR1B | 2.58343538 |
8 | CASK | 2.55232424 |
9 | WNK3 | 2.44997753 |
10 | TAOK3 | 2.39310910 |
11 | WNK4 | 2.30729202 |
12 | NTRK3 | 2.20253108 |
13 | MST1R | 2.17128215 |
14 | PKN2 | 2.15450843 |
15 | TNIK | 2.00248297 |
16 | ZAK | 1.98844178 |
17 | MAPK11 | 1.96049313 |
18 | MAP2K4 | 1.89373434 |
19 | FLT3 | 1.83734716 |
20 | ADRBK2 | 1.80986172 |
21 | OXSR1 | 1.80098850 |
22 | STK38L | 1.80098203 |
23 | PIK3CA | 1.73319674 |
24 | MAP4K2 | 1.72358760 |
25 | DYRK2 | 1.70612781 |
26 | LATS1 | 1.61644338 |
27 | ACVR1B | 1.61514073 |
28 | BCR | 1.57824147 |
29 | ABL2 | 1.45670347 |
30 | PIK3CG | 1.40366136 |
31 | TRIB3 | 1.39940441 |
32 | TYK2 | 1.36402935 |
33 | PINK1 | 1.34312137 |
34 | GRK6 | 1.33678924 |
35 | PTK6 | 1.33496509 |
36 | DAPK2 | 1.27689934 |
37 | FGFR1 | 1.22571743 |
38 | STK16 | 1.21619192 |
39 | MAP3K4 | 1.20600597 |
40 | NLK | 1.20235622 |
41 | FRK | 1.17627796 |
42 | NTRK2 | 1.17148539 |
43 | NEK9 | 1.16514155 |
44 | MAP3K7 | 1.16104180 |
45 | KDR | 1.15059916 |
46 | FGFR2 | 1.13916063 |
47 | NUAK1 | 1.09817419 |
48 | JAK2 | 1.07602104 |
49 | MET | 1.06492517 |
50 | PRKAA2 | 1.06385568 |
51 | MAPK15 | 1.00671184 |
52 | MKNK2 | 1.00587028 |
53 | PDK4 | 1.00485178 |
54 | PDK3 | 1.00485178 |
55 | NEK1 | 0.99348834 |
56 | TYRO3 | 0.98004532 |
57 | MARK1 | 0.97917364 |
58 | CSNK1D | 0.94466051 |
59 | ERBB2 | 0.94455901 |
60 | PLK3 | 0.94100324 |
61 | MAP3K10 | 0.93701334 |
62 | PRKCZ | 0.91170454 |
63 | DYRK1B | 0.90280432 |
64 | CAMK1G | 0.89392949 |
65 | PASK | 0.88967885 |
66 | CSNK1E | 0.88922426 |
67 | CSNK1G2 | 0.88159322 |
68 | MAP2K3 | 0.85877346 |
69 | GSK3A | 0.85752293 |
70 | SGK3 | 0.83720721 |
71 | CDK6 | 0.82888998 |
72 | SGK223 | 0.82126381 |
73 | SGK494 | 0.82126381 |
74 | MAP3K3 | 0.82117724 |
75 | MAPK4 | 0.81307967 |
76 | PRKACA | 0.79414992 |
77 | CSNK1A1L | 0.77169915 |
78 | PRKAA1 | 0.75761857 |
79 | PRKG1 | 0.74841190 |
80 | EPHB1 | 0.73599738 |
81 | PRKCE | 0.73267020 |
82 | MAP3K14 | 0.72981046 |
83 | PRKACG | 0.72143195 |
84 | SGK2 | 0.70286920 |
85 | EIF2AK1 | 0.67113688 |
86 | MAPK13 | 0.66276649 |
87 | SGK1 | 0.66230841 |
88 | TIE1 | 0.65016871 |
89 | PTK2 | 0.64961364 |
90 | MAP3K11 | 0.62763637 |
91 | MAPK12 | 0.62580581 |
92 | TBK1 | 0.61971585 |
93 | JAK1 | 0.61257892 |
94 | WNK1 | 0.60935322 |
95 | CSK | 0.60647985 |
96 | MAP2K6 | 0.59131516 |
97 | PLK2 | 0.58841551 |
98 | CSNK1A1 | 0.58808686 |
99 | AKT3 | 0.58737644 |
100 | CAMK2G | 0.55632287 |
101 | PDK2 | 0.55601863 |
102 | PRKACB | 0.55289403 |
103 | STK3 | 0.52535010 |
104 | IRAK3 | 0.51372233 |
105 | TSSK6 | 0.50801178 |
106 | CDK4 | 0.50506442 |
107 | CSNK1G1 | 0.49294736 |
108 | RPS6KA3 | 0.48702967 |
109 | STK39 | 0.48388779 |
110 | RIPK1 | 0.47696540 |
111 | PRKCB | 0.46306518 |
112 | BRSK2 | 0.46163155 |
113 | MAPK7 | 0.45910317 |
114 | CSNK2A1 | 0.45879681 |
115 | PDPK1 | 0.45547595 |
116 | CAMKK2 | 0.44940616 |
117 | EIF2AK3 | 0.44397503 |
118 | ICK | 0.43832981 |
119 | PRKDC | 0.43818660 |
120 | MTOR | 0.43809463 |
121 | PBK | 0.43620732 |
122 | CAMK1D | 0.42574937 |
123 | TGFBR2 | 0.42298841 |
124 | CSNK2A2 | 0.41489121 |
125 | FER | 0.41426802 |
126 | NEK2 | 0.41373987 |
127 | ATM | 0.40868356 |
128 | MKNK1 | 0.40433500 |
129 | DYRK1A | 0.40258781 |
130 | TAOK2 | 0.38827858 |
131 | GRK1 | 0.36705592 |
132 | EPHA3 | 0.36595313 |
133 | STK38 | 0.36276986 |
134 | PHKG1 | 0.36022508 |
135 | PHKG2 | 0.36022508 |
136 | PRKCQ | 0.35978277 |
137 | IGF1R | 0.35942615 |
138 | RPS6KB1 | 0.35444830 |
139 | EPHA2 | 0.35351018 |
140 | ALK | 0.35295770 |
141 | SIK2 | 0.34980100 |
142 | FGFR3 | 0.34305961 |
143 | PRKCG | 0.33580066 |
144 | STK11 | 0.32529912 |
145 | CSF1R | 0.30872892 |
146 | CAMK2D | 0.30787425 |
147 | BMX | 0.29990448 |
148 | MAP3K5 | 0.28284481 |
149 | EPHA4 | 0.27915863 |
150 | IRAK2 | 0.27665724 |
151 | GSK3B | 0.27619357 |
152 | IRAK1 | 0.27342083 |
153 | LATS2 | 0.27089588 |
154 | EGFR | 0.27009857 |
155 | MAP2K1 | 0.26744685 |
156 | PDK1 | 0.25775073 |
157 | CAMK4 | 0.24428867 |
158 | PRKCA | 0.24053139 |
159 | MAP2K2 | 0.22782871 |
160 | PAK3 | 0.22416888 |
161 | CSNK1G3 | 0.21166416 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.24912335 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45580644 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44694884 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32800359 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95683091 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81679030 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72216349 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60840861 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.55774576 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51922405 |
11 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.51210488 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.44731985 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38674091 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.38613745 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.13414014 |
16 | * Peroxisome_Homo sapiens_hsa04146 | 2.12890517 |
17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06048149 |
18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.85773725 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85714727 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84764187 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82890409 |
22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82352799 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81375437 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81007189 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78705877 |
26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78587745 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76690205 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73664957 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71713045 |
30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64348028 |
31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59477167 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54864171 |
33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54817757 |
34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54657379 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.53017682 |
36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48543775 |
37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.42160678 |
38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38566003 |
39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35867995 |
40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35556862 |
41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33223791 |
42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30817959 |
43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28792358 |
44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27029160 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26818807 |
46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23746185 |
47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17089940 |
48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15445951 |
49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13958813 |
50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09354027 |
51 | ABC transporters_Homo sapiens_hsa02010 | 1.08239988 |
52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03953259 |
53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01764244 |
54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97653103 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91850604 |
56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90095614 |
57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86353606 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83371931 |
59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82794986 |
60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82578583 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81349337 |
62 | * Lysine degradation_Homo sapiens_hsa00310 | 0.79709781 |
63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75514080 |
64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71168687 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60972127 |
66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49484858 |
67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42211454 |
68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35706738 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28816955 |
70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26856410 |
71 | Prion diseases_Homo sapiens_hsa05020 | 0.25821811 |
72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23115174 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22692044 |
74 | Protein export_Homo sapiens_hsa03060 | 0.19968206 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.19256811 |
76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.18062029 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15997730 |
78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15020456 |
79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.11116820 |
80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09799779 |
81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.09437350 |
82 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.09229286 |
83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06807432 |
84 | Phototransduction_Homo sapiens_hsa04744 | 0.03308231 |
85 | Pertussis_Homo sapiens_hsa05133 | 0.02388237 |
86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01234645 |
87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.00722253 |
88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.2470458 |
89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2356992 |
90 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2324221 |
91 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2176199 |
92 | Bladder cancer_Homo sapiens_hsa05219 | -0.2069713 |
93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1958954 |
94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1800601 |
95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1674111 |
96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1647305 |
97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1606549 |
98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1554837 |
99 | Mineral absorption_Homo sapiens_hsa04978 | -0.1492320 |
100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1474449 |
101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1425165 |
102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1399325 |
103 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1348746 |
104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1125481 |
105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1040789 |
106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0841852 |
107 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0771493 |
108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0639606 |
109 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0607007 |
110 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0594881 |
111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0532091 |
112 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0522634 |
113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0481866 |
114 | Insulin secretion_Homo sapiens_hsa04911 | -0.0217537 |